Literature DB >> 21425418

Cell selectivity and interaction with model membranes of Val/Arg-rich peptides.

Qing-Quan Ma1, An-Shan Shan, Na Dong, Yao Gu, Wen-Yu Sun, Wan-Ning Hu, Xing-Jun Feng.   

Abstract

Antimicrobial peptides are major components of the innate self-defence system and a large number of peptides have been designed to study the mechanism of action. In the present study, a small combinatorial library was designed to study whether the biological activity of Val/Arg-rich peptides is associated with targeted cell membranes. The peptides were produced by segregating hydrophilic residues on the polar side and hydrophobic residues on the opposite side. The peptides displayed strong antimicrobial activity against Gram-negative and Gram-positive bacteria, but weak haemolysis even at a concentration of 256 µM. CD spectra showed that the peptides formed α-helical-rich structure in the presence of negatively charged membranes. The tryptophan fluorescence and quenching experiments indicated that the peptides bound preferentially to negatively charged phospholipids over zwitterionic phospholipids, which corresponds well with the biological activity data. In the in vivo experiment, the peptide G6 decreased the bacterial counts in the mouse peritoneum and increased survival after 7 days. Overall, a high binding affinity with negatively charged phospholipids correlated closely with the cell selectivity of the peptides and some peptides in this study may be likely candidates for the development of antibacterial agents.
Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21425418     DOI: 10.1002/psc.1360

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  7 in total

1.  Structural insights into and activity analysis of the antimicrobial peptide myxinidin.

Authors:  Marco Cantisani; Emiliana Finamore; Eleonora Mignogna; Annarita Falanga; Giovanni Francesco Nicoletti; Carlo Pedone; Giancarlo Morelli; Marilisa Leone; Massimiliano Galdiero; Stefania Galdiero
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

2.  Strand length-dependent antimicrobial activity and membrane-active mechanism of arginine- and valine-rich β-hairpin-like antimicrobial peptides.

Authors:  Na Dong; Qingquan Ma; Anshan Shan; Yinfeng Lv; Wanning Hu; Yao Gu; Yuzhi Li
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

3.  Overexpression of atypical protein kinase C in HeLa cells facilitates macropinocytosis via Src activation.

Authors:  Ellen J Tisdale; Assia Shisheva; Cristina R Artalejo
Journal:  Cell Signal       Date:  2014-02-27       Impact factor: 4.315

4.  Broad-Spectrum Antimicrobial Activity and Low Cytotoxicity against Human Cells of a Peptide Derived from Bovine αS1-Casein.

Authors:  Juncai Hou; Zhijing Liu; Songsong Cao; Haimei Wang; Chenggang Jiang; Muhammad Altaf Hussain; Shiyue Pang
Journal:  Molecules       Date:  2018-05-19       Impact factor: 4.411

5.  Antibacterial Activity and Mechanism of Action of Bovine Lactoferricin Derivatives with Symmetrical Amino Acid Sequences.

Authors:  Changbao Sun; Yingying Li; Songsong Cao; Haimei Wang; Chenggang Jiang; Shiyue Pang; Muhammad Altaf Hussain; Juncai Hou
Journal:  Int J Mol Sci       Date:  2018-09-27       Impact factor: 5.923

6.  Characterization of the Bioactivity and Mechanism of Bactenecin Derivatives Against Food-Pathogens.

Authors:  Changbao Sun; Liya Gu; Muhammad Altaf Hussain; Lijun Chen; Li Lin; Haimei Wang; Shiyue Pang; Chenggang Jiang; Zhanmei Jiang; Juncai Hou
Journal:  Front Microbiol       Date:  2019-11-05       Impact factor: 5.640

Review 7.  Perspective of Use of Antiviral Peptides against Influenza Virus.

Authors:  Sylvie Skalickova; Zbynek Heger; Ludmila Krejcova; Vladimir Pekarik; Karel Bastl; Jozef Janda; Frantisek Kostolansky; Eva Vareckova; Ondrej Zitka; Vojtech Adam; Rene Kizek
Journal:  Viruses       Date:  2015-10-20       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.